State regulators are increasing oversight of AI mental health chatbots as new research reveals potential harms, including a Stanford study finding that chatbots worsen loneliness for isolated users, while clinicians call for companies to disclose safety data following multiple crisis incidents.
More than two-thirds of NHS mental health providers in England are planning to cut services, with half expected to eliminate jobs, threatening to increase wait times for millions of adults and children seeking mental health care.
Researchers at Washington University have discovered that severe childhood stress creates lasting changes to DNA packaging inside brain cells, forming a molecular memory of trauma that makes individuals more vulnerable to anxiety, depression, and mood disorders when facing stress as adults.
Researchers at Washington University have discovered that severe childhood stress creates lasting changes to DNA packaging inside brain cells, forming a molecular memory of trauma that makes individuals more vulnerable to anxiety, depression, and mood disorders when facing stress as adults.
A recent clinical trial found that a single dose of ketamine increases morning cortisol levels in suicidal patients for up to 24 hours, potentially explaining the drug's rapid antidepressant and anti-suicidal effects. The finding adds to understanding of ketamine's therapeutic mechanisms beyond its original use as an anesthetic.
Vistagen announced topline results from a repeat dose study of fasedienol for acute treatment of social anxiety disorder, showing favorable safety and tolerability profiles along with efficacy signals across primary and secondary endpoints in both repeat and single dose administrations.
A randomized controlled trial conducted through the NHS in England found that a single dose of psilocybin, the active compound in magic mushrooms, produced significant improvements in depression symptoms among 60 adults with treatment-resistant major depressive disorder compared to placebo, with good tolerability.
The UK government has unveiled plans to open more than 100 walk-in mental health hubs in accessible community locations including libraries, banks and high street premises across England, alongside dedicated mental health emergency departments in hospitals. Health Secretary Andy Burnham described the initiative as the 'biggest redesign of mental health services in a generation' aimed at providing earlier intervention and preventing people from reaching crisis point.
A randomized controlled trial in Germany found that dronabinol, a cannabis-derived THC medication, significantly decreased nightmares in patients with post-traumatic stress disorder in a double-blind study published in Nature Medicine.
Researchers demonstrate fingertip sensors can identify physical patterns linked to stress, anxiety and depression, while major wearable companies including Whoop, Oura, and Apple expand into healthcare applications. Amae Health partners with Google Health to integrate Fitbit and voice biomarkers for precision psychiatry.
Supernus Pharmaceuticals and Indivior Pharmaceuticals announced an all-stock merger to create a combined company with approximately $2.2 billion in annual revenue and a portfolio of 11 commercialized medicines focused on neurological, psychiatric, and addiction-related conditions. The deal, described as a merger of equals, is expected to generate $125 million in cost savings.
South Korea has implemented AI-powered cameras on Seoul's Han River bridges to detect potential suicide attempts, while researchers in the U.S. are developing AI algorithms that use physiological signals and emergency room data to identify individuals at risk of suicide.
Scientists at The University of Texas MD Anderson Cancer Center have discovered common neuroimmune signatures that may explain how rapid-acting antidepressants like ketamine and psychedelics work to reduce symptoms in treatment-resistant depression.
The British Columbia Supreme Court has ruled that provincial laws allowing forced psychiatric treatment of involuntary patients without assessing their capacity to consent are unconstitutional, giving the government six months to reform the legislation. The court found B.C. is an outlier among provinces for granting mental health facilities unilateral power to treat people against their will without independent oversight.
Bryan Johnson, the US tech entrepreneur known for his extreme longevity experiments, publicly expressed doubts about his life mission in a social media post, suggesting he may have taken his anti-aging efforts too far.
The LiBBY clinical trial found that a combination of CBD and THC rapidly and significantly reduced agitation in hospice-eligible dementia patients, with nearly 90% of participants showing behavioral improvement in the nationwide study.
An international research team led by the Central Institute of Mental Health in Mannheim has published the largest genome-wide association study on borderline personality disorder to date, analyzing data from approximately 13,000 individuals and identifying 11 genetic locations and 9 genes associated with the condition. The findings, published in Nature Genetics on July 20, 2026, represent the first significant genetic clues for this complex mental health disorder.
The U.S. Department of Health and Human Services announced more than $281 million in grant funding opportunities across 15 programs aimed at addressing addiction, overdose, and mental illness. The funding was made available through the Substance Abuse and Mental Health Services Administration (SAMHSA).
The Trump administration is moving to relaunch the specialized LGBTQ+ option for the 988 crisis intervention hotline after initially ending it, but The Trevor Project, the nonprofit that helped pioneer the service, is being excluded from eligibility to operate it.
In a stunning reversal, lawyers for Luigi Mangione informed a judge Thursday that he will no longer pursue a psychiatric defense at his state murder trial for the killing of UnitedHealthcare CEO Brian Thompson on a Manhattan sidewalk. The withdrawal means Mangione will not introduce evidence that he was experiencing an extreme mental health crisis at the time of the alleged killing.
Research published shows that ChatGPT's free version is 26 times more likely to respond inappropriately to psychotic delusions compared to paid versions, raising concerns about AI safety in mental health contexts and the disparity between free and premium AI services.
Health officials under Robert F. Kennedy Jr. explored banning certain SSRI antidepressants as part of plans to reduce their use in the United States, sparking significant debate over medication safety and federal regulatory authority.
A clinical trial of 108 adults with obesity and alcohol use disorder found that once-weekly semaglutide injections reduced heavy drinking days in the past 30 days by an average of roughly 12 days, representing a 50% reduction compared to placebo.
New research using brain imaging has revealed three distinct subtypes of ADHD, each associated with different underlying brain systems, co-occurring conditions, and learning challenges. The findings suggest that inattentive and hyperactive-impulsive symptom profiles follow separate neural pathways, potentially enabling more targeted treatment interventions.
Medical professionals and researchers are expressing serious concerns about GLP-1 receptor agonist medications like Ozempic being misused by people with eating disorders or triggering disordered eating behaviors, with patients describing the drugs as addictive and relapse-inducing.
A new study shows that suicide rates among young people dropped 11% following the U.S. launch of the 988 national suicide and crisis hotline, with increased calls to the hotline correlating with reduced suicide deaths.
Medical professionals and patients on social media are increasingly reporting a phenomenon called 'Ozempic personality,' characterized by emotional flattening and reduced ability to experience joy while taking GLP-1 medications for weight loss.
Google updated its Gemini AI assistant to more effectively direct users to mental health resources during moments of crisis, following a wrongful death lawsuit alleging its chatbot contributed to a user's distress.
Research from Emory University and University of Iowa demonstrates that noninvasive transcranial magnetic stimulation (TMS) can calm the brain's fear center and significantly reduce PTSD symptoms, offering a non-surgical, non-medication treatment option.
Kratom-related poisonings have increased by 1,200% over the past decade, with proposals to ban or regulate the plant-based substance making headlines across the United States as lawmakers and regulators grapple with safety concerns.
